Identification of a Negative Regulatory Surface within Estrogen Receptor α Provides Evidence in Support of a Role for Corepressors in Regulating Cellular Responses to Agonists and Antagonists
Authors:
- 1 August 2002
- journal article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 16 (8) , 1778-1792
Abstract
Several lines of evidence have indicated that the estrogen receptor (ER) can recruit the corepressors, nuclear receptor corepressor (NCoR) and silencing mediator of retinoid and thyroid receptors (SMRT), to target genes in the presence of tamoxifen, suggesting a possible role for NCoR/SMRT in regulating ER pharmacology. However, a tamoxifen-dependent, direct interaction between NCoR/SMRT and ER in vitro has not been demonstrated. To investigate the possible involvement of different corepressors in the actions of antiestrogen-bound ER, we have constructed a phage display library that expresses 23-amino acid peptides containing the canonical CoRNR box motif in an otherwise random background. Screening of the CoRNR box library with apo-ER or ER treated with tamoxifen or ICI 182,780 led to the isolation of peptides whose ability to interact with ER was influenced by the nature of the bound ligand. Using a series of ERalpha mutants, we found that helix 12 was not required for the binding of CoRNR box peptides, whereas disruption of helixes 3 and 5 had a marked effect on peptide binding. One mutant, ER-L372R, lost the ability to interact with CoRNR box-containing peptides without affecting its binding to LXXLL motif-containing peptides. The estradiol- and tamoxifen-mediated transcriptional activity of ER-L372R was dramatically increased by 11- and 3-fold, respectively, compared with that of wild-type ERalpha. The ICI 182,780-mediated repressional activity of this mutant was also reduced by 4-fold compared with that of wild-type ERalpha. These results suggest that leucine 372 may be an important part of the interaction surface on ER that is responsible for corepressor binding. In addition, our data suggest that corepressors, other than NCoR/SMRT, may be involved in ER signaling.Keywords
This publication has 35 references indexed in Scilit:
- Structural Insights into the Mode of Action of a Pure AntiestrogenStructure, 2001
- The Estrogen Receptor β-Isoform (ERβ) of the Human Estrogen Receptor Modulates ERα Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and Antiestrogens1Endocrinology, 1999
- Comparative Analyses of Mechanistic Differences Among Antiestrogens1Endocrinology, 1999
- Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER βProceedings of the National Academy of Sciences, 1999
- The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by TamoxifenCell, 1998
- Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexesProceedings of the National Academy of Sciences, 1998
- Molecular basis of agonism and antagonism in the oestrogen receptorNature, 1997
- Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-HydroxytamoxifenMolecular Endocrinology, 1997
- Hormone-dependent Transactivation by Estrogen Receptor Chimeras That Do Not Interact with hsp90Journal of Biological Chemistry, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences of the United States of America, 1996